Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in GlioblastomaHDACi and Imipridones Enhance Cell Death in Glioblastoma

Overview of attention for article published in Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

blogs: 1 blog

twitter: 8 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 13 X posts from 8 X users, with an upper bound of 16,273 followers.

Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma https://t.co/Jl54RV3mmd

08 Aug 2023

Reply Repost Favourite

Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma https://t.co/zfknLvns6L

18 Sep 2022

Reply Repost Favourite

RT @Franca_ole: "Activation of #ClpP protease along with inhibition of HDAC1/2 causes synthetic lethality in #GBM model systems" #HDAC inhi…

21 May 2022

Reply Repost Favourite

"Activation of #ClpP protease along with inhibition of HDAC1/2 causes synthetic lethality in #GBM model systems" #HDAC inhib (#panobinostat #romidepsin) may be effectively combined with #imipridones in glioblastoma multiforme $CMRX #ONC201 #ONC206 #ONC212

20 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.